Respiratory Pharmacists of Nigeria

07/05/2024

*"WORLD ASTHMA DAY MEETING"*

Distinguished Fellows, Senior Colleagues, Ladies and Gentlemen, Pharmacists...
Warm greetings from the National Secretariat.

ACPN in conjunction with _*Asthma and Chest Care Foundation*_ and *NiPAP* inform all CP's of the forth coming World Asthma Day Celebration Virtual Meeting scheduled for;
_Date: Wednesday, 8th May_
_Time: 11a.m WAT_
_Place: zoom virtual platform._

This promises to be an Insightful Interactive session on Current Trends and Strategies for Asthma Management with All Health Practitioners across the federation.
_Make plans to attend..._

Thanks,
MEKWUNYEI Chukwudi
NPS, ACPN.
02.04.2024

17/02/2023

RPN is inviting you to a scheduled Zoom meeting.

Topic: Management of Sarcoidosis
Time: Feb 28, 2023 09:00 PM Africa/Lagos

Join Zoom Meeting
https://us02web.zoom.us/j/89182856779?pwd=akJqVjV6TFRVcCt3c1ZVVWFCOFdydz09

Meeting ID: 891 8285 6779
Passcode: 307785

*Speaker* : Pharm Aishat Salisu
State Honors Awardee , NYSC, Cross River state.
Deputy Medical Director, PEP Foundation.
HOD Pharm dept, NYSC Clinic, Obubra, Cross River state. 2021.
President, PANS, OOU.
National VP PANS, 2018.
*Moderator* : Pharm
Tolulope O. Ajayi FPCPharm, MCPAN, MAW, DCPharm, FIBC, FIMC
*CEO, Shekinah Specialties Limited;
*Project Mgr, RPN
*Treasurer, ACPN Lagos;
*Treasurer, ACPN Lagos; Coop

**CPAN* *advancing* *patient care through Clinical pharmacy practice research & education**

Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, confer...

24/11/2022

*CLINICAL ONCOLOGY PHARMACISTS OF NIGERIA (CORxN)..* .* a *Speciality Group* of the Clinical Pharmacists of Nigeria (CPAN)

INVITES YOU TO HER 4TH EDITION CLINICAL MEETING ON THURSDAY 24TH NOVEMBER 2022

TIME: *9:00PM PROMPT*

TOPIC: *MAINTAINING HEALTH DURING ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER*

*SPEAKER* :

*OBO OKOKON ITA(MPSN, MCPAN,B.Pharm., Diploma Statistics (In view), Ph.D ( In view)

*MODERATOR:* GBONE ILUKWE (B. Pharm, MCPAN, MNSTM, MAPHePON)

*ZOOM LINK:* https://us02web.zoom.us/j/89066049268?pwd=MVkvemZtYk1FSHBlNjJseTdhclF6Zz09

*Meeting ID:* 890 6604 9268
*Password:* 659913

*ANNOUNCER:*
CORxN Education Committee

*CORxN!!!*
*...advancing direct patient cancer care through pharmacotherapy*

Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, confer...

24/11/2022

24/10/2022

Management of Chronic Obstructive Pulmonary Disease

Speaker: Pharm Tamarau-Tenna Reuben
B.Pharm MPSN
Lasuth, Ikeja.

Moderator: Pharm. Billy Shoaga B.pharm MBA.MCIM.Digital Health Professional
Public Health Pharmacist
Passionate Healthcare Volunteer

Date: *TOMORROW* Tue 25th October 2022 @ 9pm.

Join Zoom Meeting
https://us02web.zoom.us/j/89076239792?pwd=VUYzZUhWenVyeTdjZlBkc2lIT2F4UT09

Meeting ID: 890 7623 9792
Passcode: 034473

Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, confer...

20/09/2022

Nanotechnology applied to the treatment of fungal infections

Nanosponges of itraconazole in adhesive transungal patches, which can minimise drug resistance and widen the spectrum of antifungal activity against highly drug resistant fungal infections have been developed at the Chemists College Of Pharmaceutical Sciences and Research, India.

This work, applying nanotechnology, was presented in a poster at the FIP congress yesterday. Limce Thampi, head of the college’s department of pharmaceutics, said “Nanotechnology is an emerging technology for the pharmaceutical field. I see a promising future in this particular area of work, and is especially relevant for the most fragile sectors of the population and for the eldest.

01/09/2022

3D-printed medicines show promise for personalised drug delivery

Drug release properties from 3D-printed medicines vary according to the botanical origin of the starch used in their production, researchers at the University of the Basque Country, Spain, have shown.

Kizkitza González and her team loaded starches from maize and two types of potato with a non-soluble drug and found that the 3D-printed tablets produced had different geometries, behaviours and swelling capacities, causing drug release to vary from 10 minutes to six hours. Dr González suggested that a loaded drug could be released immediately to relieve pain, for example, or an antibiotic could be released more continuously.

She added that the starch-based 3D-printed tablets “displayed promising properties for future personalised drug delivery applications”. Read the full paper here: https://bit.ly/3cqVJF3

For more scientific news, follow us on Twitter [https://lnkd.in/d7gCCct] and on our Pharmaceutical Sciences at FIP LinkedIn group [https://lnkd.in/ettEXW5v].

Starch-based tablets with tailored releases were prepared by 3D printing using a hydrophobic drug. The importance of the origin of the excipient in th…

01/09/2022

https://events.fip.org/previous-fip-digital-events/.
Watch the FIP Webinar on role of pharmacists on preventing influenza and increasing vaccination coverage.

Catch up with all FIP previous webinars and digital events.

29/08/2022

25/08/2022

https://youtu.be/UPwDAXXomMg

20/08/2022

*Screening and identification of patients at risk of developing asthma/exacerbations is one of the roles of the pharmacist.*

The most common risk factors for developing asthma include having a parent with asthma, having a severe respiratory infection as a child, having an allergic condition, or being exposed to certain chemical irritants or industrial dusts in the workplace.
Allergies such as atopic dermatitis (eczema) or allergic rhinitis (hay fever),
Occupational exposures to certain dusts (industrial or wood dusts), chemical fumes and vapors, and molds
Direct exposure of cigarette smoke or indirectly or from mothers who smoked during pregnancy
Air Pollution of urban areas
Obesity in children or adults

How do we screen:
When patients *regularly* come for cough medications, and request for medications *regularly* for symptomatic relief of asthma symptoms (which include breathlessness, chest tightness, wheezing or cough usually at night or early morning), or always come in for allergy medications, then we can take the history of their symptoms and refer them for specialist care so a diagnosis can be made for asthma or excluded.(History & exam are key to asthma diagnosis)
For already diagnosed asthma patients who are on controller and reliever inhalers who *do not regularly* fill their controller meds or who *only request for reliever meds,* these are signs of an eventual exacerbation or crisis. So we should identify and educate them. We can initiate record keeping for asthma patients who fill their asthma meds prescriptions in our hospitals or neighbourhood pharmacies so as to be able to identify them and do the needful. When a child of a known asthmatic begins to come down with asthma related symptoms above, identifying them and pointing to specialist assessment is also vital.